Follow
Adam Halberstadt
Adam Halberstadt
Verified email at ucsd.edu
Title
Cited by
Cited by
Year
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer
CS Grob, AL Danforth, GS Chopra, M Hagerty, CR McKay, AL Halberstadt, ...
Archives of general psychiatry 68 (1), 71-78, 2011
13242011
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
AL Halberstadt, MA Geyer
Neuropharmacology 61 (3), 364-381, 2011
3942011
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
AL Halberstadt
Behavioural brain research 277, 99-120, 2015
3542015
PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program
GR Greer, CS Grob, AL Halberstadt
Journal of psychoactive drugs 46 (1), 73-77, 2014
1782014
Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement
AL Halberstadt, MA Geyer
Psychopharmacology 227, 727-739, 2013
1692013
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
AL Halberstadt, L Koedood, SB Powell, MA Geyer
Journal of psychopharmacology 25 (11), 1548-1561, 2011
1622011
International Union of Basic and Clinical Pharmacology. CX. Classification of receptors for 5-hydroxytryptamine; pharmacology and function
NM Barnes, GP Ahern, C Becamel, J Bockaert, M Camilleri, ...
Pharmacological reviews 73 (1), 310-520, 2021
1562021
Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
AL Halberstadt, M Chatha, AK Klein, J Wallach, SD Brandt
Neuropharmacology 167, 107933, 2020
1532020
5-HT2A and 5-HT2C receptors exert opposing effects on locomotor activity in mice
AL Halberstadt, I Van Der Heijden, MA Ruderman, VB Risbrough, ...
Neuropsychopharmacology 34 (8), 1958-1967, 2009
1532009
The phencyclidine-glutamate model of schizophrenia
AL Halberstadt
Clinical neuropharmacology 18 (3), 237-249, 1995
1261995
Effects of the hallucinogen 2, 5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response
AL Halberstadt, MA Geyer
Neuropharmacology 77, 200-207, 2014
1132014
Four factors underlying mouse behavior in an open field
S Tanaka, JW Young, AL Halberstadt, VL Masten, MA Geyer
Behavioural brain research 233 (1), 55-61, 2012
1112012
Serotonergic and nonserotonergic neurons in the dorsal raphe nucleus send collateralized projections to both the vestibular nuclei and the central amygdaloid nucleus
AL Halberstadt, CD Balaban
Neuroscience 140 (3), 1067-1077, 2006
1062006
Organization of projections from the raphe nuclei to the vestibular nuclei in rats
AL Halberstadt, CD Balaban
Neuroscience 120 (2), 573-594, 2003
992003
Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens
AL Halberstadt
Neuropharmacology of New Psychoactive Substances (NPS) The Science Behind …, 2017
952017
Effect of hallucinogens on unconditioned behavior
AL Halberstadt, MA Geyer
Behavioral neurobiology of psychedelic drugs, 159-199, 2018
872018
Chronic pain and psychedelics: a review and proposed mechanism of action
JP Castellanos, C Woolley, KA Bruno, F Zeidan, A Halberstadt, T Furnish
Regional Anesthesia & Pain Medicine 45 (7), 486-494, 2020
802020
Serotonergic hallucinogens as translational models relevant to schizophrenia
AL Halberstadt, MA Geyer
International Journal of Neuropsychopharmacology 16 (10), 2165-2180, 2013
802013
Return of the lysergamides. Part I: Analytical and behavioural characterization of 1‐propionyl‐d‐lysergic acid diethylamide (1P‐LSD)
SD Brandt, PV Kavanagh, F Westphal, A Stratford, SP Elliott, K Hoang, ...
Drug testing and analysis 8 (9), 891-902, 2016
782016
LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor
AL Halberstadt, MA Geyer
Psychopharmacology 208, 179-189, 2010
772010
The system can't perform the operation now. Try again later.
Articles 1–20